The Department of Health and Human Services cut funding for messenger ribonucleic acid vaccine development earlier this month ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal has upheld the validity of Moderna’s EP’949 patent. This decision affirms the ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.